Page last updated: 2024-08-23

epirubicin and Vaginal Neoplasms

epirubicin has been researched along with Vaginal Neoplasms in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Guo, L; Han, X; Lang, J; Leng, J; Xiang, Y1
Colombo, A; Gabriele, A; Landoni, F; Lissoni, A; Mangioni, C; Perego, P; Zanetta, G1

Trials

1 trial(s) available for epirubicin and Vaginal Neoplasms

ArticleYear
Intense neoadjuvant chemotherapy with cisplatin and epirubicin for advanced or bulky cervical and vaginal adenocarcinoma.
    Gynecologic oncology, 1997, Volume: 64, Issue:3

    Topics: Adenocarcinoma; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Epirubicin; Female; Follow-Up Studies; Humans; Hysterectomy; Neoplasm Staging; Survival Rate; Uterine Cervical Neoplasms; Vaginal Neoplasms

1997

Other Studies

1 other study(ies) available for epirubicin and Vaginal Neoplasms

ArticleYear
Vaginal adenosarcoma arising from refractory endometriosis: a case report.
    The Australian & New Zealand journal of obstetrics & gynaecology, 2010, Volume: 50, Issue:6

    Topics: Adenofibroma; Adenosarcoma; Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; CA-125 Antigen; Cisplatin; Endometriosis; Epirubicin; Etoposide; Female; Gestrinone; Humans; Hysterectomy; Ifosfamide; Membrane Proteins; Ovariectomy; Salpingectomy; Treatment Outcome; Vaginal Neoplasms; Vincristine

2010